In separate small clinical trials, two treatments showed promise that they could help patients with one of the most dire ...

The study highlights the unmet need for effective strategies to prevent chemotherapy‑induced nerve damage, which affects long ...

A medical oncologist called the late-stage clinical trial results “remarkable,” though Sasse said the drug means his body ...

Two genetic variants may help explain differences in side effects and weight loss in patients taking GLP-1 drugs.

If you've been following the weight-loss medication revolution, you've likely heard about Wegovy injections. But now there's a new option that might be even more appealing: a once-daily pill. The FDA ...

The first time the placebo effect really got under my skin was when I read that roughly one-third of people with irritable ...

Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to genetic variants, according to a ...

Researchers at the University of Colorado Anschutz may have identified why many cancer patients say food suddenly tastes ...

Originally developed to treat diabetes, a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are now stepping into the spotlight as weight loss drugs. A recent umbrella ...

Better cancer care depends on better treatment options. That’s why the Ontario Institute for Cancer Research (OICR) is supporting four Ontario-based research teams working to develop the next ...

The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, ...